|
|
|
LifeScienceHistory.com - Check us out on Instagram
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Pernix Therapeutics
| | | Phone: | (800) 793-2145 | Fax: | (862) 260-8752 | Year Established: | 1996 | Ticker: | PTX | Exchange: | NYSE | Main Contact: | George P. Jones, VP, Sales & Marketing | | Other Contacts: | Leslie White, Director of Regulatory Affairs & Quality Assurance John Sedor, Chairman & CEO Ken Piña, Senior VP, General Counsel and Chief Compliance Officer Glenn Whaley, VP, Finance
| | Company Description | Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its integrated Pernix sales force and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc. | |
|
|
|
|
|